Anivive Announces Completion of LAVERDIA®-CA1 Pivotal Field Study for Canine Lymphoma

Clinical trial sites across nine states have closed for one of the largest canine lymphoma studies Effectiveness data will soon be finalized for statistical review and FDA submission LONG BEACH, Calif., Feb. 14, 2025 /PRNewswire/ — Anivive, a software-driven pet health company, today…